Get access

Neuroleptic malignant syndrome controversies revisited—what is the incidence of neuroleptic malignant syndrome?

Authors


R. Gurrera, Mental Health, VA Boston Healthcare System, 940 Belmont Street (116A), Brockton, MA 02301, USA. E-mail: ronald_gurrera@hms.harvard.edu

No abstract is available for this article.

Ancillary